Julian Sprague, M.D., Ph.D., associate professor of medicine, was named to the myeloma subcommittee for the Alliance for Clinical Trials in Oncology. The Alliance Myeloma Committee focuses on developing trials that will improve outcomes of patients diagnosed with multiple myeloma, an incurable marrow bone disease which has widespread effects throughout the body, including the marrow, skeleton, immune system, kidneys and peripheral nervous system, and is responsible for two percent of cancer deaths.